Stockscreener 앱 받기
42.37
4.75%
-1.83
Conmed Corp 주식(CNMD)의 최신 뉴스
CONMED CFO Todd Garner to step down in March 2026 - Investing.com
CONMED Corp Announces CFO Transition - TradingView — Track All Markets
CONMED (NYSE: CNMD) details CFO Todd Garner’s exit terms and transition plan - Stock Titan
CONMED changes its finance chief but keeps 2025 goals on track - Stock Titan
Tech Rally: What technical signals suggest for CONMED Corporation stockCPI Data & Target Return Focused Picks - ulpravda.ru
CONMED (CNMD) EVP Brent Lalomia reports 401(k) share acquisitions - Stock Titan
Tributary Capital Management LLC Acquires Shares of 415,672 CONMED Corporation $CNMD - MarketBeat
CONMED Corporation (NYSE:CNMD) Receives Average Recommendation of “Reduce” from Analysts - Defense World
CONMED Corporation (NYSE:CNMD) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
Here's why you should retain CONMED stock in your portfolio now - MSN
Is There An Opportunity In CONMED (CNMD) After A 38% One Year Share Price Fall - simplywall.st
CONMED leaders to share company update at J.P. Morgan Healthcare Conference - Stock Titan
What CONMED’s Jan. 28 earnings call could reveal about 2025 - Stock Titan
CONMED (NYSE:CNMD) Cut to Strong Sell at Zacks Research - Defense World
CONMED (NYSE:CNMD) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Investor Mood: Why CONMED Corporation stock could rally strongly2025 Key Highlights & Daily Market Momentum Tracking - moha.gov.vn
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Finviz
Why Conmed (CNMD) is a Top Value Stock for the Long-Term - Yahoo Finance
Is There Now An Opportunity In CONMED Corporation (NYSE:CNMD)? - Yahoo Finance
Why CONMED Corporation stock could rally in 2025Forecast Cut & Proven Capital Preservation Methods - Улправда
Will CONMED Corporation stock outperform Nasdaq indexJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
Published on: 2025-12-19 14:29:06 - DonanımHaber
Will Exiting Gastroenterology to Refocus on Core Surgery Change CONMED’s (CNMD) Margin Expansion Narrative? - simplywall.st
Is CONMED Corporation stock near bottom after declineJuly 2025 Analyst Calls & Trade Opportunity Analysis - Улправда
Why CONMED (CNMD) Stock Is Trading Up Today - Finviz
CONMED (CNMD) Valuation Review as It Exits Gastroenterology and Refocuses on Core Growth Areas - simplywall.st
Here's Why Conmed (CNMD) is a Strong Growth Stock - Yahoo Finance
Here's Why Conmed (CNMD) is a Strong Value Stock - Yahoo Finance
Oversold Conditions For CONMED (CNMD) - Nasdaq
CONMED (NYSE:CNMD) Price Target Lowered to $52.00 at Bank of America - Defense World
CONMED (NYSE:CNMD) Shares Little Changed After Operations Update - Kalkine Media
CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio - Yahoo Finance
Conmed to exit gastroenterology business - Yahoo Finance
Is CONMED (CNMD) Trading Niche Biliary Devices For A Higher-Margin Endoscopy Future? - Yahoo Finance
Looking at the Narrative for CONMED After Analyst Model Tweaks and Capital Moves - Yahoo Finance
How Conmed Corp.Ordinary Shares (CNMD) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Here's why you should add CONMED stock to your portfolio now - MSN
CONMED (NYSE:CNMD) Hits New 52-Week LowWhat's Next? - MarketBeat
CONMED (CNMD) Passes Through 2% Yield Mark - Nasdaq
CONMED to Exit Gastroenterology Market - Medical Product Outsourcing
CONMED to exit gastroenterology product lines as part of portfolio shift - Medical Economics
Why CONMED (CNMD) Shares Are Plunging Today - Finviz
Conmed stock hits 52-week low at 40.0 USD - Investing.com
Why Is Conmed (CNMD) Up 0.1% Since Last Earnings Report? - Yahoo Finance
Why Is Conmed Stock Falling Friday?Conmed (NYSE:CNMD) - Benzinga
Conmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus - MassDevice
Conmed to conclude distribution agreement with W. L. Gore & Associates - TipRanks
Conmed to Exit Gastroenterology Product Lines, End Distribution Deal With Gore - marketscreener.com
Conmed to exit gastroenterology business, ends Gore distribution deal - Investing.com
Conmed to exit gastroenterology business, ends Gore distribution deal By Investing.com - Investing.com Canada
Conmed Exits Gastroenterology Products to Focus on Core Markets - TipRanks
CONMED Corp Announces Strategic Exit from Gastroenterology Product Lines - TradingView — Track All Markets
Conmed Corp announces exit from gastroenterology product lines - marketscreener.com
Conmed Announces Exclusive U.S. and Canadian Distribution Rights for the Gore® Viabil® Biliary Stent - marketscreener.com
Zacks.com featured highlights include Plains GP, Edison International, TD SYNNEX, CONMED and PG&E - sharewise.com
Here's Why You Should Add CONMED Stock to Your Portfolio Now - sharewise.com
Will CONMED Corporation stock keep outperforming rivals2025 Short Interest & Verified Technical Signals - Newser
Fisher Asset Management LLC Has $18.92 Million Holdings in CONMED Corporation $CNMD - Defense World
0.54%
0.71%
자본화:
|
볼륨(24시간):